Department of Ophthalmology, University Hospital Regensburg, Regensburg, Germany.
Department of Orthopaedic Surgery, Experimental Orthopaedics, Centre for Medical Biotechnology (ZMB), University of Regensburg, Regensburg, Germany.
Front Immunol. 2021 Nov 8;12:769242. doi: 10.3389/fimmu.2021.769242. eCollection 2021.
Complement Factor H-Related 3 (FHR-3) is a major regulator of the complement system, which is associated with different diseases, such as age-related macular degeneration (AMD). However, the non-canonical local, cellular functions of FHR-3 remained poorly understood. Here, we report that FHR-3 bound to oxidative stress epitopes and competed with FH for interaction. Furthermore, FHR-3 was internalized by viable RPE cells and modulated time-dependently complement component (C3, FB) and receptor (C3aR, CR3) expression of human RPE cells. Independently of any external blood-derived proteins, complement activation products were detected. Anaphylatoxin C3a was visualized in treated cells and showed a translocation from the cytoplasm to the cell membrane after FHR-3 exposure. Subsequently, FHR-3 induced a RPE cell dependent pro-inflammatory microenvironment. Inflammasome NLRP3 activation and pro-inflammatory cytokine secretion of IL-1ß, IL-18, IL-6 and TNF-α were induced after FHR-3-RPE interaction. Our previously published monoclonal anti-FHR-3 antibody, which was chimerized to reduce immunogenicity, RETC-2-ximab, ameliorated the effect of FHR-3 on ARPE-19 cells. Our studies suggest FHR-3 as an exogenous trigger molecule for the RPE cell "complosome" and as a putative target for a therapeutic approach for associated degenerative diseases.
补体因子 H 相关蛋白 3(FHR-3)是补体系统的主要调节因子,与多种疾病相关,如年龄相关性黄斑变性(AMD)。然而,FHR-3 的非经典局部、细胞功能仍知之甚少。在这里,我们报告 FHR-3 与氧化应激表位结合,并与 FH 竞争相互作用。此外,FHR-3 被存活的 RPE 细胞内化,并调节人 RPE 细胞补体成分(C3、FB)和受体(C3aR、CR3)的时间依赖性表达。在没有任何外源性血液来源蛋白的情况下,检测到补体激活产物。在处理过的细胞中观察到过敏毒素 C3a,并在 FHR-3 暴露后显示从细胞质向细胞膜的易位。随后,FHR-3 诱导 RPE 细胞依赖性促炎微环境。FHR-3-RPE 相互作用后,NLRP3 炎性小体激活和促炎细胞因子白细胞介素-1β、白细胞介素-18、白细胞介素-6 和肿瘤坏死因子-α的分泌被诱导。我们之前发表的单克隆抗 FHR-3 抗体,经过嵌合化以降低免疫原性,RET C-2-ximab,改善了 FHR-3 对 ARPE-19 细胞的作用。我们的研究表明 FHR-3 作为 RPE 细胞“complosome”的外源性触发分子,并可能成为相关退行性疾病治疗方法的潜在靶点。